Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Bernabei

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Pharmaceutics|July 30, 2020
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the LiteratureClaudio Iovino, Rodolfo Mastropasqua, Marco Lupidi, et al.
Ophthalmology and Therapy|September 13, 2024
Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular DegenerationEnrico Borrelli, Giulia Coco, Marco Pellegrini, et al.
The British Journal of Ophthalmology|June 8, 2026
12-month outcomes of photobiomodulation in dry age-related macular degeneration: a prospective multicentre randomised double-masked controlled clinical trialClaudio Iovino, Enrico Borrelli, Giulia Coco, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Pharmaceutics|July 30, 2020
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the LiteratureClaudio Iovino, Rodolfo Mastropasqua, Marco Lupidi, et al.
Ophthalmology and Therapy|September 13, 2024
Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular DegenerationEnrico Borrelli, Giulia Coco, Marco Pellegrini, et al.
The British Journal of Ophthalmology|June 8, 2026
12-month outcomes of photobiomodulation in dry age-related macular degeneration: a prospective multicentre randomised double-masked controlled clinical trialClaudio Iovino, Enrico Borrelli, Giulia Coco, et al.
Pageof 7